WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) today commended the appointment of Rep. Michael Burgess, M.D. (R-TX) as Chairman of the Health Subcommittee for the House Energy and Commerce Committee calling the physician and policymaker a “stalwart supporter of diagnostic innovation who recognizes its crucial impact on patient care.”
“Rep. Burgess has consistently demonstrated a deep and extensive understanding of health care and in particular, the issues facing clinical laboratories,” said Julie Khani, president of ACLA. “Having a physician taking the reins of a key subcommittee is a welcome development on Capitol Hill and we look forward to working closely with Rep. Burgess and Chairman Walden on issues critical to diagnostics and the patient community.”
Khani further noted, “The future of precision medicine is dependent upon robust diagnostic innovation and pragmatic public policy. ACLA members are encouraged by Rep. Burgess’ leadership appointment and pledge to work diligently with the committee to maximize patient access to diagnostics and effective treatments.”
# # #
The ACLA is a not-for-profit association representing the nation’s leading national, regional and esoteric clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies.